Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with-advanced solid tumors or non-Hodgkin's lymphoma (NHL) Meeting Abstract


Authors: Dolly, S.; Bendell, J. C.; Kindler, H. L.; Lauchle, J. O.; Krug, L. M.; Seiwert, T. Y.; Burris, H. A.; DeBono, J. S.; Wagner, A. J.
Abstract Title: Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with-advanced solid tumors or non-Hodgkin's lymphoma (NHL)
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S162
Language: English
ACCESSION: WOS:000326843601076
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70061-3
Notes: Meeting Abstract: 803 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lee M Krug
    178 Krug